Current medical research and opinion
-
Review Case Reports
Clinical experience and management considerations with long-acting risperidone.
Risperidone is the first atypical anti-psychotic available in a long-acting injectable formulation. ⋯ A wide variety of patient groups may benefit from treatment with long-acting risperidone, including patients with suboptimal efficacy, particularly as a result of partial compliance, patients experiencing side-effects with another antipsychotic agent or those with a first episode of schizophrenia. Furthermore, long-acting risperidone, with its assured medication delivery, should improve patient compliance and assist patients in achieving remission, an important step towards functional recovery.